Skip to content

Clinical trials

Osteosarcoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Country / region: Spain Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20131
20142
20173
20181
20202
20211
20221
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grupo Espanol de Investigacion en Sarcomas4
Eli Lilly and Company2
Celgene1
Cellestia Biotech AG1
Eisai Inc.1
Eisai Limited1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Fundación de investigación HM1
GlaxoSmithKline1
Gustave Roussy, Cancer Campus, Grand Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma18
Sarcoma5
Rhabdomyosarcoma4
Sarcoma, Ewing4
Ependymoma3
Glioblastoma3
Neoplasms3
Neuroblastoma3
Bone Neoplasms2
Breast Neoplasms2

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.